In the realm of molecular biology SHP-2 Small Molecules and Peptides and protein research, the SHP2 peptide has become a significant focal point for investigators studying signal transduction pathways. As a user navigating the complexities Src-homology-2-containing protein tyrosine phosphatase 2 (SHP2), encoded by the PTPN11 gene, is a 593 amino acid classical non-receptor protein tyrosine of biochemical research, I have found that understanding the structural nuances of this molecule is essential for anyone looking into the mechanisms of cellular signaling.
The Structural Architecture of SHP2
SHP2 is a multi-domain prote The SH2 domain-containing phosphatases, SHP-1 and SHP-2, are well-studied cytosolic tyrosine phosphatases that share many structural and regulatory features. in tyrosine phosphatase (PTP) that serves as a central player in cellular signaling in animals. Encoded by the *PTPN11* gene, this 593-amino-acid protein is a member of a human protein phosphatases family that is essential for various biological processes.
From my experience May 12, 2020 — SH2 domain-containing tyrosine phosphatase 2 (SHP2), encoded by PTPN11, plays a fundamental role in the modulation of several signaling reviewing technical documentation, the most fascinating aspect of SHP2 is its unique configuration, Mechanism of SHP2 activation by bis-Tyr-phosphorylated which features two Src homology 2 domains (N-SH2 and C-SH2) followed by a catalytic protein tyrosine phosphatase (PTP) domain. These SH2 domains are critical mediators of cellular signaling, acting as modules of approximately 100 amino acids that bind to specific phospho (pY)-containing peptide motifs.
Mechanisms of Activation and Interaction
Scientific literature highlights that SHP2 is a ubiquitous protein tyrosine phosphatase, whose activity is tightly regulated by phosphotyrosine-containing peptides. When we discuss SHP2 peptide interactions, we are often looking at how these motifs induce the proximity of protein tyrosine kinases and facilitate downstream signaling.
A key area of interest is the PD-1-mediated SHP2 activation. Research consistently shows that the structural reorganization of the protein—often triggered by activator peptides—allows it to transition from a basal, inhibited state to an active conformation. This is particularly relevant when considering how bis-phosphorylated peptides can wrangle the SHP2 tandem domains, forcing a conformational shift that exposes the catalytic site.
Applications in Research
For those involv Diverse Biochemical Properties of Shp2 Mutants ed in laboratory analysis, high-quality synthetic versions, such as the human SHP2 synthetic peptide (often cataloged as PEP-0409), are standard tools. These are frequently used as blocking peptides to validate the specificity of antibodies in immunoblotting or immunohistochemistry experiments.
Because SHP2 is a tyrosine phosphatase that plays a regulatory role in multiple intracellular signaling cascades, it is frequently studied in contexts where its dysregulation is suspected. It is widely recognized that SHP2 is implicated in diseases such as cancer and RASopathies, making the study of its binding kinetics a priority for those investigating the interface of cellular growth and signal modulation.
Personal Observations on SHP2 Research
In my own exploration of these molecules, I have observed that the SHP2 phosphatase functions as a pleiotropic factor. This means it can influence multiple signaling pathways simultaneously. When selecting a SHP2 peptide for experimental use, it is vital to ensure the sequence matches the targeted domain—whether that be the N-SH2 or C-SH2—to ensure accurate results in structural studies or inhibition assays.
Furthermore, the "activity-centric" model of SHP2, which w May 12, 2020 — The SHP2 structure includes two Src homology 2 domains (N-SH2 and C-SH2) followed by a catalytic protein tyrosine phosphatase (PTP) domain. as once the standard for explaining pathogenic mutations, has evolved. Modern research now suggests that the structural determinants of phosphopeptide binding are more complex, involving not just simple binding but a sophisticated reorganization of the SH2-SH2 interface.
Conclusion
Whether you are investigating the *PTPN11* gene or the complex biochemical properties of SHP2 mutants, the study of the SHP2 peptide remains a cornerstone of modern molecular research. By focusing on the structural biology of the N-SH2 and C-SH2 domains, researchers can gain deeper insights into how this protein acts as a molecular switch in the cell. As always, rigorous attention to sequence purity and binding specificity is the key to reproducible and meaningful data in this fascinating field.